Lytic induction therapy has been developed to selectively kill EBV-positive cancer cells by triggering viral reactivation using histone deacetylase inhibitors, DNA methyltransferase inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback